Advertisement
Noticias de Forex
Japan GDP Data Due On Tuesday
Japan will on Tuesday release preliminary Q4 numbers for gross domestic product, highlighting a light day for Asia-Pacific economic activity. GDP is expected to expand 0.5 percent on quarter and 2.0 percent on year after sinking 0.2 percent on quarter and 0.8 percent on year.
RTTNews |
hace 920
Swiss Stock Market Snaps Losing Streak
The Swiss stock market on Monday wrote a finish to the two-day slide in which it had given up more than 145 points or 1.3 percent.
RTTNews
|
hace 921
European Markets Close Higher On Monday
The major European markets opened higher on Monday and spent all day in the green, extending Friday's gains as investors assessed the outlook for inflation and economic growth.
RTTNews
|
hace 921
Currency Markets Pause Ahead Of U.S. CPI Data
Currency markets witnessed moderate movements in the week spanning February 6-10 ahead of the crucial CPI data release from the U.S. on February 14.EUR/USD
RTTNews
|
hace 921
India Inflation Surges To 6.52%, Crosses RBI's Target Range
India's consumer price inflation accelerated for the first time in four months in January and cut across the Reserve Bank's target corridor amid rising prices for fuel and clothing among others, according to data released by the statistics ministry on Monday. The consumer price index climbed 6.52 percent year-over-year in January, faster than the 5.72 percent gain in December.
RTTNews
|
hace 921
B2Gold To Acquire Sabina Gold & Silver In C$1.1 Bln All Stock Deal
B2Gold Corp. (BTG, BTO.TO) and Sabina Gold & Silver Corp. (SBB.TO) announced Monday that they have entered into a definitive agreement pursuant to which B2Gold has agreed to acquire all of the issued and outstanding shares of Sabina.
RTTNews
|
hace 921
Amended: Eurozone Set To Escape Recession; Inflation Outlook Downgraded
Following the favorable development in energy prices and the diversification of supply sources, the euro area is set to avoid a recession and gradually pick up pace next year, as inflation likely peaked and has loosened its grip on economic activity, the European Commission said in its interim forecast, released Monday.
RTTNews
|
hace 921
more news
Novavax Extends Partnership With U.S. Health Dept. To Deliver 1.5 Mln Addl Doses Of NVX-CoV2373
Biotechnology company Novavax, Inc. (NVAX) announced Monday a modification to its existing agreement with the U.S. Department of Health and Human Services (HHS), in collaboration with the Department of Defense, to deliver up to 1.5 million doses of the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373).
RTTNews
|
hace 921
Bally's Sees Sharply Wider Loss In Q4, Expects Revenue Growth
While reporting preliminary results for the fourth quarter and full year 2022 on Monday, casino-entertainment company Bally's Corp. (BALY) said it expects to report a net loss of $476.80 million, including non-cash goodwill and asset impairment charges of $464.0 million, compared to a net loss of $115.29 million in the year-ago quarter.
RTTNews
|
hace 921
Dye & Durham Q2 Results Miss Estimates
Dye & Durham Ltd. (DND, DND.TO) reported Monday a second-quarter net loss of C$34.8 million, a decrease of C$30.8 million, from the same period in the prior year.
RTTNews
|
hace 921
Teradata Guides Q1, FY23 Adj. EPS Above Estimates - Update
While reporting financial results for the fourth quarter on Monday, Teradata Corp. (TDC) provided earnings, adjusted earnings and revenue growth guidance for the first quarter and for the full-year 2023.
RTTNews
|
hace 921
Swiss Consumer Price Inflation Exceeds Expectations
After showing signs of slowdown, Switzerland's consumer price inflation accelerated again at the start of the year, largely reflecting higher food and energy prices, figures from the Federal Statistical Office showed on Monday. Consumer prices rose 3.3 percent on a yearly basis in January after the 2.8 percent increase in December. The rate also far exceeded economists' forecast of 2.9 percent.
RTTNews
|
hace 921
G1 Therapeutics To Discontinue Phase 3 PRESERVE 1 Trial
Oncology company G1 Therapeutics, Inc. (GTHX) announced Monday topline results from its pivotal Phase 3 PRESERVE 1 trial showing that the trial achieved its co-primary endpoints related to severe neutropenia with statistical significance.
RTTNews
|
hace 921
Stay up to date!
Add Noticias to your browser
Add To Chrome
